Concepedia

Publication | Open Access

Heat-shock protein peptide complex–96 vaccination for recurrent glioblastoma: a phase II, single-arm trial

DOIFull Paper Access

231

Citations

37

References

2013

Year

Orin Bloch, Courtney A. Crane, Yelena S. Fuks, Rajwant Kaur, Manish K. Aghi, Mitchel S. Berger, Nicholas Butowski, Susan M. Chang, Jennifer Clarke, Michael W. McDermott,
Neuro-Oncology

Abstract

The HSPPC-96 vaccine is safe and warrants further study of efficacy for the treatment of recurrent GBM. Significant pretreatment lymphopenia may impact the outcomes of immunotherapy and deserves additional investigation.

References

YearCitations

Page 1